Product Description
Daunorubicin is used to treat
leukemia and other cancers. It belongs to a class of drugs known as anthracyclines and works by slowing or stopping the growth of
cancer cells. This medication is given by injection into a vein by a health care professional.
Powerful Solution for Leukemia TherapyDaunorubicin Injection, formulated as Daunorubicin Hydrochloride 20 mg in a 10 ml single-use vial, is a vital component in the treatment of leukemia, including AML and ALL. Its proven track record in chemotherapy regimens highlights its role in effectively targeting malignant cells, making it an integral part of anticancer protocols. The sterile, ready-to-use format ensures safety and convenience for patients and healthcare providers alike.
Strict Medical Administration and Cytotoxic HandlingThis injection is only to be administered intravenously under the supervision of qualified medical professionals. Due to its cytotoxic nature, healthcare teams must employ specialized handling and disposal techniques. Each pack includes thorough usage instructions, underscoring the importance of adhering to established safety protocols during preparation and administration.
Safe Packaging and Storage for LongevityEvery vial is securely sealed and packed within a carton alongside detailed instructions to ensure correct usage. To maintain its efficacy and stability, Daunorubicin Injection must be stored at 2C to 8C and shielded from light. Observing these guidelines preserves the products 24-month shelf life, ensuring readiness for medical use when required.
FAQs of Daunorubicin Injection:
Q: How is Daunorubicin Injection administered to patients?
A: Daunorubicin Injection is administered intravenously, directly into a vein, and should only be handled and given by healthcare professionals experienced in administering cytotoxic chemotherapy agents.
Q: What are the primary uses of Daunorubicin Injection?
A: This medication is primarily indicated for the treatment of acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL) as part of combination chemotherapy regimens.
Q: When should Daunorubicin Injection be used in leukemia treatment?
A: Daunorubicin Injection is typically included in the induction and consolidation phases of leukemia treatment. Timing and dosage are determined by the treating oncologist based on individual patient protocols and disease progression.
Q: Where should Daunorubicin Injection be stored to maintain its effectiveness?
A: The vials should be stored between 2C and 8C and protected from light. Proper refrigeration ensures the medication stays effective until its expiration date.
Q: What precautions are necessary when handling Daunorubicin Injection?
A: As a cytotoxic medication, Daunorubicin requires specialized handling precautions, including the use of gloves and protective equipment, with thorough attention to safe disposal as per hospital protocols.
Q: What are the benefits of using Daunorubicin Injection in cancer therapy?
A: Daunorubicin is regarded as a cornerstone in the treatment of AML and ALL, contributing to the destruction of malignant cells and improving patient outcomes when used as directed by oncology experts.
Q: What does each vial of Daunorubicin Injection contain?
A: Each single-use glass vial contains 20 mg of Daunorubicin Hydrochloride dissolved in 10 ml of sterile water for injection, along with necessary excipients, forming a red, clear solution.